Related Experiment Video
Updated: Jul 11, 2026

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
Published on: July 20, 2019
Stat3 up-regulates expression of nicotinamide N-methyltransferase in human cancer cells
Mikio Tomida1, Hideki Ohtake, Takashi Yokota
1Research Institute for Clinical Oncology, Saitama Cancer Center, 818 Komuro, Ina, Saitama 362-0806, Japan. tomida@cancer-c.pref.saitama.jp.
Purpose:
To discover new molecular targets for cancer therapy and diagnosis, we surveyed signal transducers and activators of transcription 3 (Stat3)-regulated genes, because constitutive activation of Stat3 is associated with a wide variety of human malignancies.
Methods:
We investigated the Stat3-regulated genes in 293 cells with cDNA microarray analysis and found that Nicotinamide N-methyltransferase (NNMT) was induced on stimulation of the cells with leukemia inhibitory factor. We examined the expression of NNMT in several types of cancer cells by real-time quantitative RT-PCR. To examine the role of Stat3, Hep-G2 hepatocellular carcinoma cells were transfected with NNMT promoter-luciferase reporter construct together with conditionally active Stat3 (Stat3ER) or dominant-negative Stat3 expression vector and NNMT promoter activity was determined. The expression of NNMT and activated Stat3 in 88 colon cancer tissues and 17 normal colon tissues was examined with immunohistochemical analysis.
Results:
In Hep-G2 cells and SW480 colon cancer cells, NNMT expression increased on stimulation of the cells with interleukin 6. NNMT promoter activity in Hep-G2 cells was dependent on the activation of Stat3. MDA-MB-468 breast cancer cells and HT29 colon cancer cells expressed constitutively a high level of NNMT. Treatment of these cells with Stat3 siRNA or curcumin, which inhibited Stat3 phosphorylation, resulted in reduction of the NNMT level. We found a correlation between the expression of NNMT and activated Stat3 (P<0.001) in the colon cancer tissues.
Conclusion:
NNMT is a novel Stat3-regulated gene. Its expression is enhanced with the activation of Stat3 in colon cancer tissues. NNMT may be a potential candidate for a tumor marker of various kinds of cancers.
Insights
Nicotinamide N-methyltransferase (NNMT) is a novel gene regulated by signal transducers and activators of transcription 3 (Stat3). NNMT expression correlates with Stat3 activation in colon cancer, suggesting its potential as a tumor marker.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Constitutive activation of signal transducers and activators of transcription 3 (Stat3) is implicated in numerous human cancers.
- Identifying Stat3-regulated genes is crucial for discovering novel cancer therapeutic and diagnostic targets.
Purpose of the Study:
- To identify novel molecular targets for cancer therapy and diagnosis by surveying Stat3-regulated genes.
- To investigate the role of Nicotinamide N-methyltransferase (NNMT) as a potential Stat3-regulated gene in various cancers.
Main Methods:
- Utilized cDNA microarray analysis to identify Stat3-induced genes in 293 cells.
- Examined NNMT expression in cancer cell lines using real-time quantitative RT-PCR.
- Assessed NNMT promoter activity in response to Stat3 activation in Hep-G2 cells.
- Performed immunohistochemical analysis of NNMT and activated Stat3 in colon cancer tissues.
Main Results:
- Nicotinamide N-methyltransferase (NNMT) was identified as a Stat3-induced gene.
- NNMT expression and promoter activity were found to be dependent on Stat3 activation in cancer cells.
- A significant correlation between NNMT expression and activated Stat3 was observed in colon cancer tissues.
- NNMT levels decreased upon inhibition of Stat3 phosphorylation.
Conclusions:
- Nicotinamide N-methyltransferase (NNMT) is a newly identified Stat3-regulated gene.
- Elevated NNMT expression is associated with Stat3 activation in colon cancer.
- NNMT represents a potential candidate biomarker for various cancer types.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Nucleolus
Abnormal Proliferation